Circassia Limited
Pre-Approval PRO BETAInactive Company
No clinical trial activity in 3+ years. This company may have been acquired, shut down, or pivoted away from clinical development. Last trial started: 5/1/2016
Pipeline by Phase
Therapeutic Focus
Clinical Trials (24)
Efficacy and Safety of Grass-SPIRE Registration Study
Started: 5/1/2016
Study of Grass-SPIRE in Subjects With Grass Allergies and Asthma
Started: 4/1/2014
Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure Chamber
Started: 1/1/2014
Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and Asthma
Started: 1/1/2014
ToleroMune House Dust Mites (HDM) Exposure Chamber Study
Started: 9/1/2011
Identification of Potential Biomarkers of Response to Peptide Immunotherapy for Ragweed Allergy
Started: 3/1/2011
Safety and Tolerability of ToleroMune Grass in Grass Allergic Subjects With Rhinoconjunctivitis
Started: 7/1/2010
Safety of ToleroMune House Dust Mite (HDM) to Treat House Dust Mite Allergy in HDM Allergic Subjects With Rhinoconjunctivitis
Started: 11/1/2009
Safety of ToleroMune Ragweed to Treat Ragweed Allergy in Ragweed Allergic Subjects With Rhinoconjunctivitis
Started: 4/1/2009
Safety of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects With Controlled Asthma
Started: 3/1/2009
Effectiveness of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects
Started: 8/1/2008
Identification of Potential Biomarkers of Peptide Immunotherapy. Part 2 - Gene Array Analysis
Started: 10/1/2011
Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis
Started: 10/1/2011
Antipsoriatic Effect of a Topical Formulation for the Treatment of Psoriasis Vulgaris
Started: 3/1/2013